Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
370 artigos
A Cochrane meta-analysis of 17 RCTs finds amyloid-targeting antibodies offer minimal cognitive gains while significantly raising ARIA risk.
A 10-year Swiss cohort study finds chronic subdural hematoma surgery patients suffer sustained excess mortality and significant cognitive and functional impairments.
First 6-month RCT shows PAP therapy meaningfully improves MoCA scores and motor function in Parkinson's patients with OSA.
New JAMA Neurology analysis reveals that chronic subdural hematoma carries significant long-term neurological effects that extend far beyond the risk of bleeding recurrence.
Stanford researchers find pioglitazone and liraglutide improve CNS insulin signaling, measured via neuron-derived vesicles in blood.
New research reveals how amyloid-β triggers a calcium-cholesterol cascade in brain cells that clogs the glymphatic system — and how statins may reverse it.
Vá além do básico e explore a maquinaria molecular por trás do fluxo glinfático, dos canais de água AQP4, dos linfáticos meníngeos e por que sua disfunção impulsiona a neurodegeneração.
Descubra como o seu cérebro elimina resíduos tóxicos enquanto você dorme — e por que essa limpeza noturna é uma das coisas mais importantes que você pode fazer pela saúde cerebral a longo prazo.
Large European study of 10,000+ older adults reveals loneliness impacts baseline memory but doesn't speed up mental decline over time.
Researchers develop novel immunotherapy using modified brain cells to target Alzheimer's pathology directly in the brain.
New review reveals how protein clumps and cellular powerhouses work together to drive neurodegeneration in Parkinson's disease.
New research reveals how brain immune cells destroy smell-related nerve connections in early Alzheimer's, offering hope for earlier detection.
